Profil
Kevin Harris is currently the Chief Commercial Officer at VectivBio Holding AG since 2019.
Prior to this, he worked at Incyte Corp.
for 10 years from 2009 to 2019, where he held the position of Group Vice President-Global Product Strategy from 2017 to 2019.
Mr. Harris completed his undergraduate degree at Cornell University and obtained an MBA from Kellogg School of Management.
Anciens postes connus de Kevin Harris
| Sociétés | Poste | Fin |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 01/10/2019 |
| VECTIVBIO HOLDING AG | Corporate Officer/Principal | - |
Formation de Kevin Harris
| Kellogg School of Management | Masters Business Admin |
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |